Cat. No. | 製品名 | CAS No. | Purity | Chemical Structure |
---|---|---|---|---|
T38343 | Quercetin pentaacetate | 1064-06-8 | 98% |
|
Quercetin pentaacetate (Pentaacetylquercetin) has diverse biological activities, including antioxidant, anti-inflammatory, and anticancer properties. Quercetin p... | ||||
TN3048 | 4-Methoxycinnamaldehyde | 1963-36-6 | 98% |
|
4-Methoxycinnamaldehyde (p-Methoxycinnamaldehyde) is an active ingredient of Agastache rugosa.4-Methoxycinnamaldehyde has cytoprotective activity against respira... | ||||
T77100 | Nirsevimab | 1989556-22-0 | 98% |
Nirsevimab
|
Nirsevimab (MEDI8897) is a recombinant human respiratory syncytial virus (RSV) monoclonal antibody with a modified Fc region. Nirsevimab efficiently targets RSV-... | ||||
T76992 | Suptavumab | 1629615-23-1 | 98% |
Suptavumab
|
Suptavumab (REGN2222) is a human monoclonal antibody. Suptavumab neutralizes conserved epitopes on subtypes A and B on RSV. Suptavumab can be used to study RSV i... | ||||
T76907 | Palivizumab | 188039-54-5 | 98% |
|
Palivizumab (MEDI 493) is a humanized RSV-specific monoclonal antibody that selectively inhibits epitopes at the F protein A antigenic site of RSV subtypes A and... | ||||
T2621 | Rostafuroxin | 156722-18-8 | 98% |
|
Rostafuroxin (PST 2238) has been used in trials studying the treatment of Essential Hypertension. | ||||
T12774 | RSV-IN-1 | 861139-16-4 | 98% |
|
RSV-IN-1 is an inhibitor of human respiratory syncytical virus (hRSV) and reduced the virus infectivity with IC50 value of 0.11 μM. | ||||
T7353 | RSV604 | 676128-63-5 | 98% |
|
RSV604 ((S)-1-(2-Fluorophenyl)-3-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)urea) is an inhibitor of respiratory syncytial virus (RSV) that binds ... | ||||
T3417 | Amentoflavone | 1617-53-4 | 99.22% |
|
Amentoflavone (3',8''-Biapigenin), as a potent inhibitor of CYP3A4 and CYP2C9, can interact with many other medications. CYP3A4 and CYP2C9 are proteins used for ... | ||||
TQ0085 | Presatovir | 1353625-73-6 | 99.38% |
|
Presatovir (GS-5806) (GS-5806) is a novel, orally bioavailable RSV fusion inhibitor (mean EC50: 0.43 nM). | ||||
T60016 | VV116 | 2647442-33-7 | 99.42% |
|
VV116 (JT001) is a selective and orally active nucleoside antiviral agent against respiratory syncytial virus (RSV) and SARS-CoV-2 infection. | ||||
T11760 | KIN101 | 610753-87-2 | 99.46% |
|
KIN101 (3-(4-Bromophenyl)-7-[(methylsulfonyl)oxy]-4-oxo-4H-chromene), an isoflavone agonist of IRF-3 dependent signaling, induces IRF-3 nuclear translocation. KI... | ||||
T9197 | Sisunatovir hydrochloride | 1903763-83-6 | 99.49% |
|
Sisunatovir hydrochloride (RV521 HCl) is an orally available inhibitor of the RSV-F protein that has exhibited potent efficacy against a panel of clinical isolat... | ||||
T1024 | Roflumilast | 162401-32-3 | 99.64% |
|
Roflumilast (APTA 2217) is an orally available, long-acting inhibitor of phosphodiesterase (PDE) type 4 (PDE4), with anti-inflammatory and potential antineoplast... | ||||
T4380 | Ac-CoA Synthase Inhibitor1 | 508186-14-9 | 99.81% |
|
Ac-CoA Synthase Inhibitor1 (ACSS2 inhibitor) is the most potent and specific inhibitor of acetate-dependent acetyl-CoA synthetase 2 (ACSS2). | ||||
T0684 | Ribavirin | 36791-04-5 | 99.82% |
|
Ribavirin (Tribavirin) is a synthetic nucleoside analog of ribofuranose with activity against hepatitis C virus and other RNA viruses. | ||||
T15621 | Rilematovir | 1383450-81-4 | 99.82% |
|
Rilematovir (JNJ-678) is an inhibitor of fusion protein with antiviral activity and low cytotoxicity. Rilematovir can be used in studies about respiratory syncyt... | ||||
TQ0034 | Lumicitabine | 1445385-02-3 | 98% |
|
Lumicitabine (ALS-008176) is an inhibitor of RSV polymerase. | ||||
T82005 | JNJ-8003 | 98% |
|
|
JNJ-8003 is a potent inhibitor of RSV Polymerase, effectively impeding the early stages of RNA transcription and replication by inhibiting nucleotide polymerizat... | ||||
T79221 | RSV L-protein-IN-5 | 851658-28-1 | 98% |
|
RSV L-protein-IN-5 (Compound E) serves as a potent inhibitor of the Respiratory Syncytial Virus (RSV), with an EC50 value of 0.1 μM. It targets RSV polymerase wi... |